A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.
The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...
Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.
Because TB is, airborne, highly infectious, and increasingly resistant to antibiotics, treatment and prevention of the disease often...
A study published in JAMA Internal Medicine today demonstrated that a smartphone app could lead to small improvements in self-reported medication adherence among participants with poorly controlled hypertension. However, participants using the app had no change in systolic blood pressure compared to their counterparts that were not using the app, according to the study.
Medication adherence has...
Seattle, Washington-based Pillsy has officially launched its digital medication adherence and tracking tool, which consists of a smart pill bottle and companion app.
PillsyCap, as the product is known, uses Bluetooth to sense when the bottle is opened and closed, and syncs with the app to automatically tracks when a user takes their pills, reminds them when they forget a dose or warns if multiple...
Japanese digital health company Welby has collaborated with Janssen, a pharmaceutical division of Johnson & Johnson, to develop a mobile app for people with attention deficit hyperactivity disorder, or ADHD. The app will be available on iOS and Android throughout Japan.
Aozora, the task management app, was created by Welby and will be distributed by Janssen to people with ADHD who are...
London-based Echo has launched its medication management app, now available to all NHS providers in England. It is backed by $2.24 million (1.8 million British pounds) in new funding led by British venture capital firm LocalGlobe.
Co-founded by Dr. Sai Lakshmi, a former Apple executive and Stephen Bourke, a former executive with UK retail pharmacy chain LloydsPharmacy, Echo aims to make it easier...
New York City based-startup Quio, which is working on a sensor-enabled drug injector and companion software for the clinical trial and chronic disease market, has raised $1.05 million in seed funding. The undisclosed investors include those with expertise in health insurance, pharmaceuticals and clinical research, the company revealed.
Quio is developing Smartinjector, a connected medication...
Cincinnati-based MedaCheck, which makes a medication reminder platform that can be used on a smartphone or tablet, recently finished a medication adherence study with the Cincinnati Children’s Hospital Medical Center, finding that the digital tool significantly improved medication use among adolescents.
The study looked at 40 adolescents between the age of 13 and 20 who were receiving treatment...
Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to patients filling certain brand-name prescriptions for chronic conditions, starting with diabetes and eventually expanding to others. The platform will be web-based, but Walgreen's site is optimized for...
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
